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“coverage gap days” was conducted for the study population. A
MPR of ≥0.8 was considered adherent. RESULTS: Of approxi-
mately 13,000 standard Medicare Part D patients, 189 had
claims for both a statin and a PO anti-diabetic during January
2006, and subsequently experienced the coverage gap. The
number of patients reaching the “doughnut hole” or coverage
gap in a given month ranged from 4 to 41, starting in April. The
average “pre-gap” and “gap” periods were 242 days and 123
days, respectively. The average MPR for PO anti-diabetics during
the “pre-gap” period was 24% higher than during the “gap”
(0.92 vs. 0.70). For the statins, there was an 18% decrease in
the average MPR between the “pre-gap” period and the “gap”
period (0.87 vs. 0.72). CONCLUSION: The overall medication
compliance (i.e. MPR) of statins and oral anti-diabetics
decreased during the 2006 Medicare Part D beneﬁt coverage gap
period. On average, patients became more non-adherent with
their statin and oral anti-diabetic therapies during the “gap”
period.
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OBJECTIVES: This study sought to evaluate the impact of con-
verting to insulin administration with an insulin aspart analog
pen from vial/syringe on medication adherence among type 2
diabetes patients. METHODS: A pre-post conversion approach
was adopted using an integrated medical and pharmacy claims
database from >50 managed care health plans in the United
States. Adults diagnosed with type 2 diabetes who converted to
insulin aspart pen therapy (NovoLog® FlexPen®) [index event]
from either human or analog insulin vials between July 2001 and
December 2002 with no prior use of FlexPen® for six months
were identiﬁed. Medication adherence in the pre and post-index
periods was measured using medication possession ratio (MPR).
Paired t-test was performed to test the statistical differences in
adherence rates. RESULTS: Data from 670 patients (prior analog
insulin vial/syringe users: 328; human insulin vial/syringe users:
342) newly treated with FlexPen® were analyzed. Mean patient
age was 45.7 years (SD: 13.8 years) and 50.8% were male. Upon
initiating FlexPen®, MPR was signiﬁcantly improved to 70%
(SD: 32%) in comparison to 65% (SD: 29%), p < 0.01, prior to
FlexPen® use. Previous human vial/syringe users [human pre-
mix users: 76% vs. 82%; p = 0.01, and NPH users: 66% vs.
70%; p = 0.02] showed the highest improvement in adherence
in the post-index period of 5 percentage points (71% vs. 76%;
p = 0.01), as compared to 4 percentage points (61% vs. 65%; p
= 0.01) among prior analog vial/syringe users [glargine users:
63% vs. 67%; p = 0.03, and analog pre-mix users: 59% vs. 63%;
p = 0.03]. CONCLUSION: Medication adherence to insulin
therapy based on MPR was signiﬁcantly improved following the
initiation of insulin aspart analog pen in type 2 diabetes patients.
Further analyses should evaluate the impact of improved adher-
ence on clinical health outcomes and associated costs.
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OBJECTIVES: To examine the relationship between eating
healthy foods and exercising regularly on physical health (PH),
mental health (MH), and perceived health status (PHS) among
type II diabetics. METHODS: The 2005 Center for Disease
Control and Prevention’s Behavioral Risk Factor Surveillance
System, a cross-sectional survey, was utilized. Respondents were
considered type II diabetics if diagnosis occurred minimally at
age 30. Eating healthy foods was deﬁned as eating at least 5 serv-
ings of fruits and vegetables daily. Exercising regularly was
deﬁned as meeting the recommendations for moderate and/or
vigorous exercise. Due to impact on quality of life we included
demographics, socioeconomic status, comorbidities, diabetic
complications, and insulin use as covariates. Poisson regressions
were used to compare the monthly number of PH or MH days
associated with eating healthy foods and exercising regularly.
Logistic regression determined the association between PHS
(good versus poor) and eating healthy foods or exercising regu-
larly. RESULTS: Among 21,590 type II diabetics identiﬁed, the
majority were Caucasian, older, urban, hypertensive, and did not
meet recommendations. Eating 3–4 servings of fruits and veg-
etables was associated with 0.1 (4.4%) and 2.9 (17.6%) more
days in which PH and MH was good compared to 5 servings (p
= 0.0113 and p < 0.0001). Consuming 1–2 servings of fruit and
vegetables daily was associated with lower PHS (p < 0.0001).
No exercise was associated with 5.8 (34.0%) fewer days of good
PH (p < 0.0001), 3.6 (21.9%) fewer days of good MH (p <
0.0001), and 8% lower odds of good PHS (p < 0.0001) com-
pared to people who exercise regularly. Annual household
income <$15,000 consistently was associated with poorer PH 
(p < 0.0001), MH, (p < 0.0001), and PHS (p < 0.0001). CON-
CLUSION: Glycemic effects from fruits and vegetables may con-
tribute to more PH and MH days for 3–4 daily servings
compared to 5. Causation cannot be inferred from these results
due to its cross-sectional and observational nature.
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OBJECTIVES: The risk of developing cardiovascular and other
life threatening diseases is strongly linked to increased body
weight. This is particularly relevant to people with type 2 dia-
betes (T2D) in whom over 80% are overweight. Limited data
exist on the impact on Health Related Quality of Life (HRQOL)
of Body Mass Index (BMI) for people with type 2 diabetes. The
aim of this study was to characterize the impact of BMI on
HRQOL for people with and without T2D in England.
METHODS: Data from the Health Survey for England 2003
(HSE03) was evaluated. HSE03 consisted of a stratiﬁed random
sample designed to provide data about the general population
living in private households in England. Observations for 13,233
non-diabetic patients and 461 patients with T2D were included.
HRQOL was measured using the EQ-5D. Overall HRQOL dif-
ferences were investigated using t-tests. Analyses of variance
